Big Step for Women trying to link Cancer and DES In-Utero Hormone

DiEthylStilbestrol Lawsuit, Courthouse News Service, 2012

Big Step for Women trying to link Cancer and In-Utero HormoneJanuary 2012, in a blow to pharmaceutical companies, a federal judge agreed to let experts testify that a pregnant woman’s use of synthetic estrogen increases the risk of her daughter developing breast cancer.

In a case filed in 2011 in the District of Massachusetts, 53 DES daughters with breast cancer sued 14 pharmaceutical companies, including Eli Lilly and Co., Merck & Co., and Bristol-Myers Squibb. They allege that their exposure to the drug substantially increased their risk of contracting breast cancer.

Last week, U.S. Magistrate Judge Marianne Bowler agreed that the plaintiffs can have experts testify about the DES-cancer link.

Read Courthouse News Service article, January 25, 2012.

Time for Actions: did you SIGN THE PETITION?

More DES DiEthylStilbestrol Resources

Have your say! Share your views